Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
|
|
CANNAPHARMARX, INC. (CPMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/13/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 10/03/2023 |
3
| Panek Anthony Michael (Director) has filed a Form 3 on CANNAPHARMARX, INC. |
| 11/21/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/22/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/12/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/11/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/08/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 08/02/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 05/23/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/16/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/15/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/31/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 02/16/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data|
Docs:
|
"CannaPharmaRx Acquiring Oklahoma Cannabis Facility CALGARY, AB / ACCESSWIRE / February 10, 2022 / CannaPharmaRx, Inc. , a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a Letter of Intent to purchase an operating Cannabis facility located in Braman, Oklahoma. The property consists of 35,000 square feet of cultivation capacity, with a planned, phased expansion to 65,000 square feet, by the end of 2022 and up to five harvests per year. The purchase will be completed via a secured note and will include the transfer of licenses. The transaction is expected to close prior to March 31, 2022. The facility has ongoing growing and sales operations and should the deal be finalized CannapharmaRx will realize first harvest and sales fro..." |
|
| 11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/16/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 07/16/2021 |
8-K
| Quarterly results |
| 06/22/2021 |
8-K
| Quarterly results |
| 06/14/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 06/10/2021 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 06/09/2021 |
8-K
| Quarterly results |
| 05/26/2021 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 05/17/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 05/14/2021 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 05/05/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/03/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/21/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/14/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/14/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 04/01/2021 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 01/28/2021 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/27/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/22/2021 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"Commitment Letter",
"CannapharmaRx, Inc. Announces Non-Dilutive Commitment Financing for Assets and Facilities Located in Cremona, AB CALGARY, AB / ACCESSWIRE / January 19, 2021 / CannapharmaRx, Inc. a future leader in ultramodern, highly efficient cannabis production facilities in Canada announced today that it has secured a commitment letter for twelve million dollars for the recently announced purchase of the cannabis cultivation and production business located at, and operated out of Cremona, Alberta and other acquisitions of cannabis cultivation and production facilities. The loan, which is fully collateralized by the facilities, will provide CannapharmaRx with the capital to complete the purchase of the 55,200 square foot facility, which is capable of producing 5,200 kilograms of cannabis biomass per yea..." |
|
|
|
|